18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma: Radiology - Pictorial essay

Rm Subramaniam, B. Wilcox, Mc Aubry, J. Jett, Pj Peller

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Malignant pleural mesothelioma (MPM) is the most common primary pleural tumor and its incidence is rising. Its diagnosis, staging and response assessment are challenging for imaging. Integrated positron emission tomography (PET)/CT increases the accuracy of overall staging in patients with mesothelioma and improves the selection of patients for curative surgical resection. It is particularly useful in identifying occult distant metastases. It may be used to predict prognosis and to assess the metabolic response to therapy.

Original languageEnglish (US)
Pages (from-to)160-170
Number of pages11
JournalJournal of Medical Imaging and Radiation Oncology
Volume53
Issue number2
DOIs
StatePublished - Apr 2009

Fingerprint

Mesothelioma
Deoxyglucose
Radiology
Positron-Emission Tomography
Patient Selection
Neoplasm Metastasis
Incidence
Neoplasms
Therapeutics
Malignant Mesothelioma
Positron Emission Tomography Computed Tomography

Keywords

  • FDG
  • Mesothelioma
  • PET/CT

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Oncology

Cite this

18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma : Radiology - Pictorial essay. / Subramaniam, Rm; Wilcox, B.; Aubry, Mc; Jett, J.; Peller, Pj.

In: Journal of Medical Imaging and Radiation Oncology, Vol. 53, No. 2, 04.2009, p. 160-170.

Research output: Contribution to journalArticle

@article{16fe4ad2620e4916b5a22694f68bf298,
title = "18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma: Radiology - Pictorial essay",
abstract = "Malignant pleural mesothelioma (MPM) is the most common primary pleural tumor and its incidence is rising. Its diagnosis, staging and response assessment are challenging for imaging. Integrated positron emission tomography (PET)/CT increases the accuracy of overall staging in patients with mesothelioma and improves the selection of patients for curative surgical resection. It is particularly useful in identifying occult distant metastases. It may be used to predict prognosis and to assess the metabolic response to therapy.",
keywords = "FDG, Mesothelioma, PET/CT",
author = "Rm Subramaniam and B. Wilcox and Mc Aubry and J. Jett and Pj Peller",
year = "2009",
month = "4",
doi = "10.1111/j.1754-9485.2009.02058.x",
language = "English (US)",
volume = "53",
pages = "160--170",
journal = "Journal of Medical Imaging and Radiation Oncology",
issn = "1754-9477",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - 18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma

T2 - Radiology - Pictorial essay

AU - Subramaniam, Rm

AU - Wilcox, B.

AU - Aubry, Mc

AU - Jett, J.

AU - Peller, Pj

PY - 2009/4

Y1 - 2009/4

N2 - Malignant pleural mesothelioma (MPM) is the most common primary pleural tumor and its incidence is rising. Its diagnosis, staging and response assessment are challenging for imaging. Integrated positron emission tomography (PET)/CT increases the accuracy of overall staging in patients with mesothelioma and improves the selection of patients for curative surgical resection. It is particularly useful in identifying occult distant metastases. It may be used to predict prognosis and to assess the metabolic response to therapy.

AB - Malignant pleural mesothelioma (MPM) is the most common primary pleural tumor and its incidence is rising. Its diagnosis, staging and response assessment are challenging for imaging. Integrated positron emission tomography (PET)/CT increases the accuracy of overall staging in patients with mesothelioma and improves the selection of patients for curative surgical resection. It is particularly useful in identifying occult distant metastases. It may be used to predict prognosis and to assess the metabolic response to therapy.

KW - FDG

KW - Mesothelioma

KW - PET/CT

UR - http://www.scopus.com/inward/record.url?scp=66249102670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66249102670&partnerID=8YFLogxK

U2 - 10.1111/j.1754-9485.2009.02058.x

DO - 10.1111/j.1754-9485.2009.02058.x

M3 - Article

C2 - 19527361

AN - SCOPUS:66249102670

VL - 53

SP - 160

EP - 170

JO - Journal of Medical Imaging and Radiation Oncology

JF - Journal of Medical Imaging and Radiation Oncology

SN - 1754-9477

IS - 2

ER -